Skip to Content

Pfizer LLN 100 (Lorbrena 100 mg)

Generic Name: lorlatinib

Pill with imprint Pfizer LLN 100 is Purple, Elliptical / Oval and has been identified as Lorbrena 100 mg. It is supplied by Pfizer Inc..

Lorbrena is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Lorbrena 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer LLN 100

Lorbrena 100 mg Pfizer LLN 100

Lorbrena

Generic Name
lorlatinib
Imprint
Pfizer LLN 100
Strength
100 mg
Color
Purple
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0231

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.